AI智能简历诊断!

想知道你的简历存在什么问题吗?

从简历规范度、职业形象塑造、职场经历、核心能力、职场竞争力五个维度综合评估,为你的求职保驾护航!

立即诊断
杭州中泰实业集团有限公司-logo

杭州中泰实业集团有限公司

1000-9999人

公司优势

杭州中泰实业集团有限公司成立于1994年,是一家专注于研发和生产转椅托盘、五星脚、洗衣机配件、灯具配件等金属制品的民营领军企业,是国内领先的转椅底盘制造商之一。位于杭州市萧山区,距离杭州萧山国际机场仅30分钟车程,交通便捷。

公司配置了省级企业技术中心与检测中心,配备了先进的机械加工和检测设备,包括加工中心、数控车床、自动化焊接设备以及办公椅耐久性测试、推背测试、冲击测试、强度拉力测试等专业设备,确保产品的高质量产出。

目前,公司提供超过200种不同型号的转椅底盘与20多种五星脚,每款产品均通过了BIFMA、TUV、EN、Afrdi、BS、BV、SGS等国际标准认证,并拥有专利保护。所有底盘均由中国太平洋财产保险股份有限公司承保。

秉持“质量稳定、价格合理、交货及时、服务至上”的原则,中泰的产品远销国内外市场,与国际知名办公家具集团及国内一线办公家具企业建立了稳固的合作关系,共同构建了高效的供应链体系。

2009年,公司荣获国家高新技术企业称号,2010年被认定为省级技术中心,连续多年被评为萧山区百强企业、杭州市出口百强、萧山区著名商标、杭州市名牌产品、农行AAA级企业、浙江省椅业协会副会长单位、杭州家具协会理事长单位等荣誉。

面对未来,中泰将致力于深化技术创新与行业应用的融合,为客户提供更全面的产品解决方案,不断扩展产品线。为此,公司将持续优化团队结构,强化核心竞争力,以实现业务的持续增长与壮大。

AI智能简历诊断!

想知道你的简历存在什么问题吗?

从简历规范度、职业形象塑造、职场经历、核心能力、职场竞争力五个维度综合评估,为你的求职保驾护航!

立即诊断

热招职位

主办会计1-1.5万

1、准确、及时地做好账务和结算工作,进行会计核算,填制和审核会计凭证,登记明细账

压铸领班9千-1.2万

模具的调试和试模:对新模具进行调试,确保模具在使用时能够稳定地发挥作用。同时进行

相关职位

主办会计9千-1万

背景:公司是一家为从事AI行业的企业(人工智能、大模型等)提供算力租赁服务的互联

主办会计5千-8千

1、负责公司日常账务处理、审核及账务报表出具

2、开票及纳税申报,分析、核对税

主办会计7000-8000元

1、负责公司的全盘账事物,在上级领导和监督下定期完成量化的工作要求,并能独立处理

主办会计6000-12000元

岗位职责:
1.负责公司账务.税务处理.报表编制;
2.负责公司成本单据处理

主办会计(诸暨)8-12万/年

在财务经理领导下,完成会计工作。

跨境电商主办会计1万-1.5万

1、负责网店的全套账务处理并出具相关报表

2、负责往来账的核对和清理及财务数据

20,861+ 岗位更新等你来订阅

一键订阅最新的岗位,每周送达

您可以在邮箱中随时取消订阅

深圳市丝毫精密机械有限公司,成立于2013年8月23日,位于深圳市宝安区新桥街道新二社区南岭路2号A栋301,所属行业为其他机械设备及电子产品批发。公司员工1-49人,融资情况未公开。

广州法莱模具设计有限公司
招聘简章

一.企业介绍
广州法莱模具设计有限公司致力于为全球挤压模具制造企业提供专业的模具设计及相关领域的专业技术方案。广州法莱是欧洲领先铝型材挤压模具制造商PHOENIX NEDERLAND B.V.在中国设立的分支机构,集团总部位于意大利。PHOENIX集团是欧洲铝型材行业的领军企业,在欧洲大陆、荷兰、西班牙、德国、迪拜、美国等地设有分支机构和工厂。其主营业务包括:
1. 运输业:高速列车车厢的主体形状零件、结构性零件等模具。
2. 建筑业:用于住宅和商用建筑物内部的型材模具,例如摩天大楼的外墙。
3. 汽车业:汽车保险杠、减震器、防侵入杆、发动机支架等铝型材模具。
4. 航空业:飞机机翼内部的主体形状零件、结构性零件等的韧性合金模具。

广州法莱模具设计有限公司获得政府授予的“技术先进型服务企业”、“广州市科技创新小巨人企业”等荣誉,并于2017年获得国家颁发的“高新技术企业证书”。目前处于快速发展阶段,为满足业务需求,现诚聘模具设计技术人员。一经录用,公司将提供系统的培训及良好的职业发展机会。

二、公司薪酬福利
1. 薪酬:月薪3000-6000元+绩效奖金。
2. 工作时间:每周40小时,超时加班按国家规定支付1.5-3倍加班费。
3. 保险:为员工缴纳五险一金(养老保险、失业保险、工伤保险、医疗保险、生育保险和住房公积金),并对表现优秀的员工额外提供商业保险,涵盖门诊和住院费用。
4. 节假日:员工享有带薪年假、婚假、产假、丧假等。
5. 各项活动:节日福利、年度旅游、年度健康体检等。
6. 公司提供完善的培训机制,培训周期从3个月到6个月不等。优秀员工有机会前往意大利总部进行深入培训。公司为每位员工提供良好的培训和发展空间,实现企业和员工的双赢。

三、应聘方式
请将简历发送至E-mail: HRrecruitment.FARA@phoenix-spa.com,并在邮件主题中注明姓名、应聘职位及联系方式。

Guangzhou Runsheng Cytomed Technology Co., Ltd. is a Sino-foreign joint venture biotechnology enterprise dedicated to cell medicine R&D and clinical translational research. The founder and academic leader of the company, Professor Ruan Runsheng, holds a postdoctoral degree from the University of Zurich in Switzerland, is a senior researcher at the National University of Singapore's Department of Medicine, a chief researcher at the Institute of Bioengineering and Nanotechnology of the Singapore Science and Technology Agency, and a member of the European Society of Medical Oncology (ESMO). He has also been included in the US New Century 500 Scientists and the Marquis' Who's Who Yearbook of the United States. Professor Ruan Runsheng has long been committed to the research and development of cellular immunology, with his latest achievement being the Tvac? tumor personalized precision combined immunotherapy technology.

Founded on September 24, 2019, in Nansha, Guangzhou, the company focuses on exploring and developing the clinical applications of Tvac? tumor personalized precision combined immunotherapy technology. This technology uses genomics, proteomics, and other omics technologies along with tumor immunology to achieve individualized precision treatment, marking an important direction for future cancer treatments.

Currently, the company has established four platforms: bioinformatics, proteomics, peptide synthesis, and cellular immunity. These platforms are equipped with high-speed local servers and cloud platforms, ultra-high-throughput 106-channel peptide synthesizers, liquid mass spectrometers, PCR instruments, Elispot, flow cytometers, RTCA, and cell culture rooms. These advanced facilities ensure robust support for the screening of new antigens and the development of peptide drugs. The company has built a highly specialized technical R&D team leveraging its platform advantages. Core team members come from prestigious institutions such as the Hong Kong University of Science and Technology, Technical University of Denmark, Stanford University School of Medicine, Harvard Medical School, and Macquarie University in Australia, all holding master's or doctoral degrees. Their expertise spans molecular biology, biochemistry, tumor immunology, clinical medicine, and industrialization.

The company has established strategic partnerships with institutions such as the National University Hospital of Singapore, Guangdong-Hong Kong-Macao Greater Bay Area Postdoctoral Science and Technology Innovation Public Research Center, the First Affiliated Hospital of Sun Yat-sen University, the Second Affiliated Hospital of Guangzhou Medical College, Guangdong Provincial People's Hospital, and Guangzhou First People's Hospital. Tvac? technology is undergoing steady clinical trials, with smooth progress. Plans are underway to submit an NDA for Tvac? within the next three years, aiming for formal clinical application in tumor treatment. Simultaneously, the company is advancing other tumor cell therapy R&D and clinical translation projects.

In 2021, the company partnered with the Guangdong-Hong Kong-Macao Greater Bay Area Postdoctoral Science and Technology Innovation Public Research Center to establish a postdoctoral research station, continuously attracting and nurturing high-end biomedical talent. It aims to provide a platform for international researchers pursuing the dream of medical practice.

The company is currently staffed primarily by R&D personnel, with two foreign experts, and maintains a flexible organizational structure and fresh corporate culture. It is a dynamic and energetic cell medicine R&D team with international vision and top-tier standards. Moving forward, the company will closely align with market demands, applying professional technology to medical institutions and patients, and creating an innovative technology platform that integrates scientific development, talent cultivation, and shared benefits.

北京世通仁和数码科技有限公司,规模为50-150人,类型为民营公司,行业为餐饮业。